Infections with rapidly growing mycobacteria: Report of 20 cases

International Journal of Infectious Diseases

Volumn 7, Issue 3, 2003, Pages 198-205

  Sungkanuparph, Somnuek ^a,b   Sathapatayavongs, Boonmee ^a   Pracharktam, Roongnapa ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFAZOLIN; CEFOXITIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; EAR DROPS; ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; LINCOMYCIN; MEROPENEM; NETILMICIN; OFLOXACIN; PENICILLIN G; PREDNISOLONE; RIFAMPICIN; SPARFLOXACIN; TEICOPLANIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADULT; AGED; ANEMIA; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CHRONIC OTITIS MEDIA; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG RESPONSE; EYE INFECTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG INFECTION; LYMPHADENITIS; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; PSORIASIS; RETROSPECTIVE STUDY; SKIN ABSCESS; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; THAILAND;

EID: 0142184289     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(03)90052-X     Document Type: Article

References (38)

1. Wallace RJ Jr, Swenson JM, Silcox VA, et al. Spectrum of diseases due to rapidly growing mycobacteria. Rev Infect Dis 1983; 5:657-679.
2. Drabick JJ, Duffy PE, Samlaska CP, et al. Disseminated Mycobacterium chelonae subspecies chelonae infection with cutaneous and osseous manifestations. Arch Dermatol 1990; 126:1064-1067.
3. Wallace RJ Jr, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 1992; 166:405-412.
4. Fonseca E, Alzate C, Canedo T, Contreras F. Nodudar lesions in disseminated Mycobacterium fortuitum infection. Arch Dermatol 1987; 123:1603-1604.
5. Wright JE. Non-tuberculous mycobacterial lymphadenitis. Aust NZ J Surg 1996; 66:225-228.
6. Pesce RR, Fejka S, Colodny SM. Mycobacterium fortuitum presenting as an asymptomatic enlarging pulmonary nodule. Am J Med 1991; 91:310-312.
7. Rolston KVI, Jones PG, Fainstein V, Bodey GP. Pulmonary disease caused by rapidly growing mycobacteria in patients with cancer. Chest 1985; 87:503-506.
8. Kesten S, Chaparro C. Mycobacterial infections in lung transplant recipients. Chest 1999; 115:741-745.
9. Gran JT, Eng J, Refvem OK, et al. Monoarthritis due to Mycobacterium chelonae. J Rheumatol 1987; 14:852-853.
10. Ford JG, Huang AJW, Pflugfelder SC, et al. Nontuberculous mycobacterial keratitis in South Florida. Ophthalmology 1998; 105:1652-1658.
11. Huang SCM, Soong HK, Chang JS, Liang YS. Nontuberculous mycobacterial keratitis: a study of 22 cases. Br J Ophthalmol 1996; 80:962-968.
12. Matoba A. Mycobacterium chelonae keratitis. Am J Ophthalmol 1987; 103:595-596.
13. Ambler JS, Meisler DM, Zakov ZN, et al. Endogenous Mycobacterium chelonae endophthalmitis. Am J Ophthalmol 1989; 108:338-339.
14. Lowry PW, Jarvis WR, Oberle AD, et al. Mycobacterium chelonae causing otitis media in an ear-nose-and throat practice. N Engl J Med 1988; 319:978-982.
15. Austin WK, Lockey MW. Mycobacterium fortuitum mastoiditis. Arch Otolaryngol 1976; 102:558-560.
16. Raad II, Vartivarian S, Khan A, Bodey GP. Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev Infect Dis 1991; 13:1120-1125.
17. Hoy JF, Rolston KVI, Hopper RL, Bodey GP. Mycobacterium fortuitum bacteremia in patients with cancer and long term venous catheter. Am J Med 1987; 83:213-217.
18. Clegg HW, Foster MT, Sanders WE Jr, Baine WB. Infection due to organisms of Mycobacterium fortuitum complex after augmentation mammoplasty: clinical and epidemiologic features. J Infect Dis 1983; 147:427-433.
19. Montoliu J, Gatell JM, Ponal J, et al. Disseminated visceral infection with Mycobacterium fortuitum in a hemodialysis patient. Am J Nephrol 1985; 5:205-211.
20. Ingram CW, Tanner DC, Durack DT, Kernodle GW Jr, Corey GR. Disseminated infection with rapidly growing mycobacteria. Clin Infect Dis 1993; 16:463-471.
21. Wallace RJ Jr, O'Brien R, Glassroth J, Raleigh J, Dutt A. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis 1990; 142:940-953.
22. Heifets LB, Jenkins PA. Speciation of mycobacteria in clinical laboratories. In: Gangadharam PRJ, Jenkins PA, eds. Mycobacteria I: Basic aspects. New York: Chapman & Hall, 1998:308-351.
23. Cynamon MH, Klemens SP. Drug susceptibility tests for Mycobacterium fortuitum and Mycobacterium chelonae. In: Heifets LB, ed. Drug susceptibility in the chemotherapy of mycobacterial infections. Miami, FL: CRC Press, 1991: 147-160.
24. Woods GL, Washington JA II. Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis 1987; 9:275-294.
25. Choonhakarn C, Chetchotisakd P, Jirarattanapochai K, Mootsikapun P. Sweet's syndrome associated with nontuberculous mycobacterial infection: a report of five cases. Br J Dermatol 1998; 139:107-110.
26. Chetchotisakd P, Mootsikapun P, Anunnatsiri S, et al. Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity. Clin Infect Dis 2000; 30:29-34.
27. Franklin DJ, Starke JR, Brady MT, Brown BA, Wallace RJ Jr. Chronic otitis media after tympanostomy tube placement caused by Mycobacterium abscessus: a new clinical entity? Am J Otol 1994; 15:313-320.
28. Robin JB, Beatty BF, Dunn S, et al. Mycobacterium chelonei keratitis after radical keratotomy. Am J Ophthalmol 1986; 102:72-73.
29. Roussel TJ, Stern WH, Goodman DF, Whitcher JP. Postoperative mycobacterial endophthalmitis. Am J Ophthalmol 1989; 107:403-406.
30. Swenson JM, Wallace RJ Jr, Silcox VA, Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother 1985; 28:807-811.
31. Young LS, Berlin OGW, Inderlied CB. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria. Am J Med 1987; 82(4A):23-26.
32. Wallace RJ Jr, Brown BA, Onyi GO. Susceptibilities of Mycobacterium fortuitum biovar fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother 1991; 35:773-775.
33. Wallace RJ Jr, Bedsole G, Sumter G, et al. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother 1990; 34:65-70.
34. Brown BA, Wallace RJ Jr, Onyi GO, DeRosas V, Wallace RJ III. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother 1992; 36:180-184.
35. Dalovisio JR, Pankey GA. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin. J Infect Dis 1978; 137:318-321.
36. Chittasobhaktra T, Vibhagool A, Prachaktam R. Clinical manifestation and drug susceptibility of rapidly growing mycobacteria. J Infect Dis Antimicrob Agents 1999; 16:109-114.
37. Wallace RJ Jr, Tanner D, Brennan PJ, Brown BA. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 1993; 119:482-486.
38. Tebas P, Sultan F, Wallace RJ Jr, Fraser V. Rapid development of resistance to clarithromycin following monotherapy for disseminated infection in a heart transplant patient. Clin Infect Dis 1995; 20:443-444.